LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-13 Cr | ₹39 Cr | ₹-12 Cr | ₹-61 Cr | ₹-5.55 Cr |
What is the latest Consolidated Net Profit of LYKA LABS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-13 Cr |
Mar2023 | ₹39 Cr |
Mar2022 | ₹-12 Cr |
Mar2021 | ₹-61 Cr |
Mar2020 | ₹-5.55 Cr |
How is Consolidated Net Profit of LYKA LABS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-13 Cr | Negative | |
Mar2023 | ₹39 Cr | Positive | |
Mar2022 | ₹-12 Cr | Negative | |
Mar2021 | ₹-61 Cr | Negative | |
Mar2020 | ₹-5.55 Cr | - |
Compare Consolidated Net Profit of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹426.3 Cr | 3.8% | 8.4% | 14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | -0.5% | -8.4% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -2.4% | 7.2% | 50.6% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -0.7% | -3.7% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -1.4% | -3.9% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.5% | 5.6% | 5.1% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 3.8% |
8.4% |
14.1% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses